Sio Gene Therapies Inc
NASDAQ:SIOX
Sio Gene Therapies Inc
Tax Provision
Sio Gene Therapies Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sio Gene Therapies Inc
NASDAQ:SIOX
|
Tax Provision
-$290k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Tax Provision
-$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Tax Provision
-$617m
|
CAGR 3-Years
28%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Tax Provision
-$582m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Tax Provision
-$748m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-56%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Tax Provision
-$184.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
6%
|
See Also
What is Sio Gene Therapies Inc's Tax Provision?
Tax Provision
-290k
USD
Based on the financial report for Dec 31, 2022, Sio Gene Therapies Inc's Tax Provision amounts to -290k USD.
What is Sio Gene Therapies Inc's Tax Provision growth rate?
Tax Provision CAGR 3Y
-61%
Over the last year, the Tax Provision growth was -383%. The average annual Tax Provision growth rates for Sio Gene Therapies Inc have been -61% over the past three years .